A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of <i>Streptococcus pneumoniae</i> capsular polysaccharide-Reference-Cited by-同舟云学术

A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide

Published:2024 Issue:2 Volume:13 Page:91
ISSN:2287-3651
Container-title:Clinical and Experimental Vaccine Research
language:en
Short-container-title:Clin Exp Vaccine Res

Author:

Sari Ratna Fathma¹²^ORCID,Fadilah Fadilah³^ORCID,Maladan Yustinus²^ORCID,Sarassari Rosantia²^ORCID,Safari Dodi²^ORCID

Affiliation:

1. Master’s Programme in Biomedical Sciences, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.

2. Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia.

3. Medical Chemistry Department, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.

Publisher

XMLink

Link

https://ecevr.org/pdf/10.7774/cevr.2024.13.2.91

Reference73 articles.

1. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection

2. Centers for Disease Control and Prevention. Pneumococcal disease [Internet]. Atlanta (GA). Centers for Disease Control and Prevention. 2023. cited 2023 Aug 29. Available from: https://www.cdc.gov/pneumococcal/about/facts.html

3. Risk of Pneumococcal Disease in US Adults by Age and Risk Profile

4. Centers for Disease Control and Prevention. FastStats: pneumonia [Internet]. Atlanta (GA). Centers for Disease Control and Prevention. 2022. cited 2023 Sep 27. Available from: https://www.cdc.gov/nchs/fastats/pneumonia.htm

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development;Vaccines;2024-08-28

2. Prevalence of Respiratory Pathogens in Nasopharyngeal Swabs of Febrile Patients with or without Respiratory Symptoms in the Niakhar Area of Rural Senegal;Pathogens;2024-08-02